Testing a fast-acting blood pressure medicine for brain bleeding

This trial is testing a medication called clevidipine to see how well it lowers blood pressure in people who have recently experienced an intracerebral hemorrhage—a type of stroke caused by bleeding in the brain. The study will compare how quickly clevidipine gets patients' blood pressure under control compared to other standard intravenous blood pressure medicines. Researchers hope this medication may help prevent further brain damage and improve outcomes after this type of stroke.

When someone has a bleeding stroke, their blood pressure often spikes dangerously high, which can make the bleeding worse and increase the risk of brain damage. The challenge is controlling blood pressure quickly and reliably during those critical first hours. This trial will determine whether the medication works faster and more reliably than current standard treatments.